Skip to main content
OpenTrials
Completed

NCT Number: NCT01892631

Text Messaging Reminders for Influenza Vaccine in Primary Care

Influenza morbidity and mortality cause a substantial financial burden to the NHS and to the UK as a whole. Influenza vaccine is safe and effective but is required annually because the circulating strain of virus changes each year. In the UK in 2012, the Chief Medical Officer (CMO) recommended that at least 75% of elderly people (aged 65+) and 75% people under 65 with certain chronic conditions (e.g. chronic heart disease, diabetes, asthma, etc) should be vaccinated. While primary care practices are achieving these targets for elderly patients, those set for younger patients with chronic conditions are not being met, with a third of patients being missed in the 2011/12 flu season and with no substantial improvements in uptake in the past decade. Therefore strategies to increase flu vaccine uptake in these patients are required.

Previous trials have shown that patient reminders can increase vaccine uptake and in particular, text messaging has shown to work in some populations in the United States as a cheap, simple and effective reminder. However, whether the same is true in UK general practice is unclear. The use of text messaging in the NHS for appointment reminders is also increasing as it is cheap, quick and effective. Text messaging is already used in roughly 30% of practices to remind patients about their flu vaccine but there has been no trial addressing its effectiveness. Therefore, we propose a trial of a text messaging flu vaccine reminder in patients aged under 65 who have a chronic condition. We hypothesise that practices that send a text message will have increased flu vaccine uptake.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–64 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

London School of Hygiene and Tropical Medicine

London, Select County, WC1E 7HT, United Kingdom

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • practices must use text messaging software to communicate with patients;
  • practices must not have used a text message to remind patients aged under 65 about influenza vaccine in the 2012/13 influenza season.
  • practices will send the text message to eligible patients who are aged between 18 and 65, with one of the following risk conditions: chronic respiratory disease, chronic liver disease, chronic kidney disease, chronic heart disease, chronic neurological disease, immunosuppression

Exclusion criteria

  • practices will not send the text message to pregnant women.

Treatment and study plan

Text message influenza vaccination reminder

Other

Practices in the text messaging intervention arm will be asked to send a text message to patients under 65 at risk of influenza.

Standard care

Other

Practices in the standard care arm will be asked to proceed with their seasonal influenza campaign as planned.

Primary outcomes

  1. Proportion of patients at risk who received flu vaccine

    Time frame: up to 9 months

Secondary outcomes

  1. Proportion of practices reporting 'yes' to difficulties

    Time frame: up to 3 months

    Proportion of practices reporting 'yes' that they had difficulties in sending the text message to patients

  2. Recruitment rate

    Time frame: 3 months after initial contact

    This is a pilot feasibility study and recruitment of practices to the trial is an outcome.

  3. Practice delivery of text message

    Time frame: One month after study start (October 1st 2013)

    Did the practice send the text message to eligible patients and was the content of the message as described in the protocol.

  4. Were outcome data available

    Time frame: up to 9 months

    Were outcome data regarding text message and flu vaccine uptake available.

Sponsors and collaborators

Lead sponsor

London School of Hygiene and Tropical Medicine

Other

Collaborators

  • National Health Service, United Kingdom
  • Wellcome Trust

Registry information

Official study title

A Feasibility Study for a Cluster Randomised Trial of Text Messaging Reminders for Influenza Vaccine in Patients Under 65 in Clinical Risk Groups in English Primary Care.

Acronym: TXT4FLUJAB

Important dates

Study start
2013
Primary completion
2015
Study completion
2015
First posted
Jul 4, 2013
Registry last updated
Oct 24, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.